These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 34160460)

  • 21. A comparative crossover study on the treatment of hemifacial spasm and blepharospasm: preseptal and pretarsal botulinum toxin injection techniques.
    Lolekha P; Choolam A; Kulkantrakorn K
    Neurol Sci; 2017 Nov; 38(11):2031-2036. PubMed ID: 28884242
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of techniques of botulinum toxin injections for blepharospasm and hemifacial spasm.
    Sacramento DRC; Lima A; Maia DP; Cunningham M; Maciel RH; Camargos ST; Cardoso F
    Mov Disord; 2019 Sep; 34(9):1401-1403. PubMed ID: 31251420
    [No Abstract]   [Full Text] [Related]  

  • 23. Facial asymmetry in patients with hemifacial spasm before and after botulinum toxin A treatment.
    Xiao L; Pan Y; Zhang X; Hu Y; Cai L; Nie Z; Pan L; Li B; He Y; Jin L
    Neurol Sci; 2016 Nov; 37(11):1807-1813. PubMed ID: 27431279
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Low-dose botulinum toxin a for treatment of blepharospasm and hemifacial spasm.
    Poonyathalang A; Preechawat P; Jamnansiri U
    Jpn J Ophthalmol; 2005; 49(4):327-8. PubMed ID: 16075337
    [No Abstract]   [Full Text] [Related]  

  • 25. Difference in response to botulinum toxin type A treatment between patients with benign essential blepharospasm and hemifacial spasm.
    Cannon PS; MacKenzie KR; Cook AE; Leatherbarrow B
    Clin Exp Ophthalmol; 2010 Oct; 38(7):688-91. PubMed ID: 20456439
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Complications of botulinum toxin application: differences between hemifacial spasm and post-facial palsy synkinesis.
    Cakmak MA; Sahin S; Cinar N; Karsidag S
    Acta Neurol Belg; 2014 Dec; 114(4):331. PubMed ID: 24647748
    [No Abstract]   [Full Text] [Related]  

  • 27. Long-term outcome of flexible onabotulinum toxin A treatment in facial dystonia.
    Bladen JC; Feldman I; Favor M; Dizon M; Litwin A; Malhotra R
    Eye (Lond); 2019 Mar; 33(3):349-352. PubMed ID: 30202071
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fifteen-year experience in treating blepharospasm with Botox or Dysport: same toxin, two drugs.
    Bentivoglio AR; Fasano A; Ialongo T; Soleti F; Lo Fermo S; Albanese A
    Neurotox Res; 2009 Apr; 15(3):224-31. PubMed ID: 19384595
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Low-dose treatment of cervical dystonia, blepharospasm and facial hemispasm with albumin-diluted botulinum toxin type A under EMG guidance. An open label study.
    Rollnik JD; Matzke M; Wohlfarth K; Dengler R; Bigalke H
    Eur Neurol; 2000; 43(1):9-12. PubMed ID: 10601802
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment Patterns and Outcomes in Botulinum Therapy for Patients With Facial Synkinesis.
    Shinn JR; Nwabueze NN; Du L; Patel PN; Motamedi KK; Norton C; Ries WR; Stephan SJ
    JAMA Facial Plast Surg; 2019 May; 21(3):244-251. PubMed ID: 30703206
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Botulinum toxin A injection in the treatment of hemifacial spasm.
    Chen RS; Lu CS; Tsai CH
    Acta Neurol Scand; 1996 Sep; 94(3):207-11. PubMed ID: 8899054
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pain relief in patients receiving periocular botulinum toxin A.
    Harrison AR; Erickson JP; Anderson JS; Lee MS
    Ophthalmic Plast Reconstr Surg; 2008; 24(2):113-6. PubMed ID: 18356715
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Can the Jankovic-assessment be used as an alternative to electromyography? A cross-sectional study on facial dystonia patients treated with Botulinum toxin.
    Di Stadio A; Dipietro L; Gambacorta V; Cristi MC; Faralli M; Della Volpe A; Ricci G
    Am J Otolaryngol; 2019; 40(6):102278. PubMed ID: 31477366
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Botulinum toxin in the treatment of facial synkinesis and hyperkinesis.
    Filipo R; Spahiu I; Covelli E; Nicastri M; Bertoli GA
    Laryngoscope; 2012 Feb; 122(2):266-70. PubMed ID: 22252570
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-term efficacy of botulinum toxin A for treatment of blepharospasm, hemifacial spasm, and spastic entropion: a multicentre study using two drug-dose escalation indexes.
    Cillino S; Raimondi G; Guépratte N; Damiani S; Cillino M; Di Pace F; Casuccio A
    Eye (Lond); 2010 Apr; 24(4):600-7. PubMed ID: 19648904
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Costs and efficacy of type A botulinum toxin for the treatment of essential blepharospasm and hemifacial spasm].
    Lasalvia CG; Pereira Lde S; da Cunha MC; Kitadai SP
    Arq Bras Oftalmol; 2006; 69(5):701-5. PubMed ID: 17187139
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Botulinum toxin therapy for focal dystonia].
    Hahn K; Niklai E; Garzuly F; Szupera Z
    Orv Hetil; 2009 Jul; 150(29):1381-4. PubMed ID: 19581172
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Botulinum toxin for blepharospasm and hemifacial spasm: stability of duration of effect and dosage over time.
    Drummond GT; Hinz BJ
    Can J Ophthalmol; 2001 Dec; 36(7):398-403. PubMed ID: 11794389
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long-term therapy with botulinum toxin in facial synkinesis: Retrospective data analysis of data from 1998 to 2018.
    Alipour S; Pick C; Jansen S; Rink S; Klußmann JP; Grosheva M
    Clin Otolaryngol; 2021 Jul; 46(4):758-766. PubMed ID: 33534183
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long-term changes in duration of relief with botulinum toxin treatment of essential blepharospasm and hemifacial spasm.
    Ainsworth JR; Kraft SP
    Ophthalmology; 1995 Dec; 102(12):2036-40. PubMed ID: 9098314
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.